These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35536283)

  • 1. Antibody responses to SARS-CoV-2 vaccination in patients with acute myeloid leukaemia and high risk MDS on active anti-cancer therapies.
    Chan WY; Zhu C; Sanchez E; Gupta R; Fielding AK; Khwaja A; Payne EM; O'Nions J
    Br J Haematol; 2022 Aug; 198(3):478-481. PubMed ID: 35536283
    [No Abstract]   [Full Text] [Related]  

  • 2. Humoral response to mRNA-based COVID-19 vaccine in patients with myeloid malignancies.
    Mori A; Onozawa M; Tsukamoto S; Ishio T; Yokoyama E; Izumiyama K; Saito M; Muraki H; Morioka M; Teshima T; Kondo T
    Br J Haematol; 2022 Jun; 197(6):691-696. PubMed ID: 35226358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of COVID-19 mRNA vaccines in patients with acute myeloid leukemia and myelodysplastic syndrome.
    Helfgott DC; Racine-Brzostek S; Short KJ; Zhao Z; Christos P; Nino I; Niu T; Contreras J; Ritchie EK; Desai P; Samuel M; Roboz GJ
    Leuk Lymphoma; 2023 Mar; 64(3):662-670. PubMed ID: 36282213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective T-cell response to COVID-19 vaccination in acute myeloid leukaemia and myelodysplastic syndromes.
    Loke J; Upasani V; Gaskell C; Fox S; Fletcher R; Thomas C; Hopkins L; Kumari A; Tang T; Yafai E; Boucher R; Homer V; Toth A; Chan YLT; Randall K; Rider T; O'Nions J; Drew V; Pillai A; Dungarwalla M; Murray D; Khan A; Wandroo F; Moore S; Krishnamurthy P; Huang YJ; Knapper S; Byrne J; Zhao R; Craddock C; Parry H; Moss P; Stanworth SJ; Lowe DM
    Br J Haematol; 2023 Aug; 202(3):498-503. PubMed ID: 37303189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential Antibody Response to mRNA COVID-19 Vaccines in Healthy Subjects.
    Wheeler SE; Shurin GV; Yost M; Anderson A; Pinto L; Wells A; Shurin MR
    Microbiol Spectr; 2021 Sep; 9(1):e0034121. PubMed ID: 34346750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of SARS-CoV-2 mRNA intramuscular vaccination in patients with muscular disorders.
    Kasai R; Funato M; Maruta K; Yasuda K; Minatsu H; Ito J; Takahashi K
    Front Immunol; 2023; 14():1103196. PubMed ID: 36825020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients With Inflammatory Bowel Diseases Have Impaired Antibody Production After Anti-SARS-CoV-2 Vaccination: Results From a Panhellenic Registry.
    Zacharopoulou E; Orfanoudaki E; Tzouvala M; Tribonias G; Kokkotis G; Kitsou V; Almpani F; Christidou A; Viazis N; Mantzaris GJ; Tsafaridou M; Karmiris K; Theodoropoulou A; Papathanasiou E; Zampeli E; Michopoulos S; Tigkas S; Michalopoulos G; Laoudi E; Karatzas P; Mylonas I; Kyriakos N; Liatsos C; Kafetzi T; Theocharis G; Taka S; Panagiotopoulou K; Koutroubakis IE; Bamias G
    Inflamm Bowel Dis; 2023 Feb; 29(2):228-237. PubMed ID: 35394529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody and T cell responses to COVID-19 vaccination in patients receiving anticancer therapies.
    Rouhani SJ; Yu J; Olson D; Zha Y; Pezeshk A; Cabanov A; Pyzer AR; Trujillo J; Derman BA; O'Donnell P; Jakubowiak A; Kindler HL; Bestvina C; Gajewski TF
    J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35732350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma.
    Lim SH; Campbell N; Johnson M; Joseph-Pietras D; Collins GP; O'Callaghan A; Fox CP; Ahearne M; Johnson PWM; Goldblatt D; Davies AJ
    Lancet Haematol; 2021 Aug; 8(8):e542-e544. PubMed ID: 34224667
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibody responses to Sputnik Vaccination in naïve and COVID 19-recovered vaccine recipients, India.
    Sapkal G; Deshpande GR; Tilekar B; Yadav P; Abraham P; Salunke A; Patil C; Deshpande K; Patil R; Pawar N; Joshi A; Vaidya A; Shivankar A
    J Travel Med; 2022 May; 29(3):. PubMed ID: 35325194
    [No Abstract]   [Full Text] [Related]  

  • 11. Distinct immune responses in the early phase to natural SARS-CoV-2 infection or vaccination.
    Peng P; Deng H; Li Z; Chen Y; Fang L; Hu J; Wu K; Xue J; Wang D; Liu B; Long Q; Chen J; Wang K; Tang N; Huang AL
    J Med Virol; 2022 Dec; 94(12):5691-5701. PubMed ID: 35906179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine-Induced Antibody Responses against SARS-CoV-2 Variants-Of-Concern Six Months after the BNT162b2 COVID-19 mRNA Vaccination.
    Jalkanen P; Kolehmainen P; Haveri A; Huttunen M; Laine L; Österlund P; Tähtinen PA; Ivaska L; Maljanen S; Reinholm A; Belik M; Smura T; Häkkinen HK; Ortamo E; Kantele A; Julkunen I; Lempainen J; Kakkola L
    Microbiol Spectr; 2022 Apr; 10(2):e0225221. PubMed ID: 35262410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 anti-spike antibodies after vaccination in pediatric heart transplantation: A first report.
    Spinner JA; Julien CL; Olayinka L; Dreyer WJ; Bocchini CE; Munoz FM; Devaraj S
    J Heart Lung Transplant; 2022 Feb; 41(2):133-136. PubMed ID: 34911654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed kinetics of SARS-CoV-2 IgG antibody production in kidney transplant recipients following the third dose of COVID-19 vaccination.
    Matsunami M; Suzuki T; Yashima J; Kuji H; Matsue K
    Clin Exp Nephrol; 2023 Jan; 27(1):98-99. PubMed ID: 35931918
    [No Abstract]   [Full Text] [Related]  

  • 15. Decreased antibody response to influenza vaccine with an enhanced antibody response to subsequent SARS-CoV-2 vaccination in patients with chronic hepatitis B virus infection.
    He T; Ling N; Zhang G; Xiang D; Hu P; Peng M; Cai D; Zhang D; Chen M; Ren H
    Immun Inflamm Dis; 2023 Jan; 11(1):e759. PubMed ID: 36705404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does ABO blood group influence antibody response to SARS-CoV-2 vaccination?
    Vicentini C; Bordino V; Cornio AR; Meddis D; Ditommaso S; Giacomuzzi M; Memoli G; Bert F; Zotti CM
    Vox Sang; 2022 May; 117(5):754-755. PubMed ID: 34962291
    [No Abstract]   [Full Text] [Related]  

  • 17. Haemodialysis patients show a highly diminished antibody response after COVID-19 mRNA vaccination compared with healthy controls.
    Simon B; Rubey H; Treipl A; Gromann M; Hemedi B; Zehetmayer S; Kirsch B
    Nephrol Dial Transplant; 2021 Aug; 36(9):1709-1716. PubMed ID: 33999200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of age, gender, previous SARS-CoV-2 infection, and pre-existing diseases in antibody response after COVID-19 vaccination: A review.
    Fernandes MDCR; Vasconcelos GS; de Melo ACL; Matsui TC; Caetano LF; de Carvalho Araújo FM; Fonseca MHG
    Mol Immunol; 2023 Apr; 156():148-155. PubMed ID: 36921489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can Individuals with Suboptimal Antibody Responses to Conventional Antiviral Vaccines Acquire Adequate Antibodies from SARS-CoV-2 mRNA Vaccination?
    Ogura W; Ohtsuka K; Matsuura S; Okuyama T; Matsushima S; Yamasaki S; Miyagi H; Sekiguchi K; Ohnishi H; Watanabe T
    Viruses; 2022 May; 14(5):. PubMed ID: 35632698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterizing Longitudinal Antibody Responses in Recovered Individuals Following COVID-19 Infection and Single-Dose Vaccination: A Prospective Cohort Study.
    Olmstead AD; Nikiforuk AM; Schwartz S; Márquez AC; Valadbeigy T; Flores E; Saran M; Goldfarb DM; Hayden A; Masud S; Russell SL; Prystajecky N; Jassem AN; Morshed M; Sekirov I
    Viruses; 2022 Oct; 14(11):. PubMed ID: 36366515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.